MadamLead eFFECTOR Therapeutics ( NASDAQ: EFTR ) on Monday said that it has terminated its employees and will wind down its operations, as it looks for potential strategic alternatives for the company’s development programs. This decision was made at a special meeting of the board of directors. Further, eFFECTOR Therapeutics ( EFTR ) plans to voluntarily request a delisting of its securities and expects its securities to be delisted in the near term.
The board of directors appointed Craig R. Jalbert, age 62, as the company’s CEO, President, Treasurer and Secretary, and sole member of the board. Jalbert has served as a principal of the Foxborough, Massachusetts accounting firm of Verdolino & Lowey, P.
C. since 1987. Source: Press Release.
